Know Cancer

or
forgot password

High Frequency Ultrasound and Contrast Enhanced Ultrasound of Patients Treated for Deterioration of Crohn's Disease


N/A
18 Years
N/A
Open (Enrolling)
Both
Crohn's Disease

Thank you

Trial Information

High Frequency Ultrasound and Contrast Enhanced Ultrasound of Patients Treated for Deterioration of Crohn's Disease


Inclusion Criteria:



- Deterioration of Crohn's disease

- CDAI>150

- Treated with systemic steroids or TNF alfa inhibitors

- Lesion found on ultrasound

Exclusion Criteria:

- Disease location not reachable with ileocolonoscopy

- Pregnancy

- Acute coronary disease

- Unstable coronary disease

- Previous allergic reaction to SonoVue or its components

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Remission defined by Crohns disease activity index (CDAI)<150

Outcome Time Frame:

52 weeks from inclusion

Safety Issue:

No

Principal Investigator

Trygve Hausken, PhD

Investigator Role:

Study Director

Investigator Affiliation:

Nastional Center of Gastroenterological Ultrasonography, Haukeland University Hospital, Bergen, Norway

Authority:

Norway:National Committee for Medical and Health Research Ethics

Study ID:

22209

NCT ID:

NCT01074580

Start Date:

November 2009

Completion Date:

December 2014

Related Keywords:

  • Crohn's Disease
  • Crohn's disease
  • sonography
  • contrast enhanced ultrasound
  • Crohn Disease

Name

Location